Indoximod: Additional Phase Ib/II data

Data from 28 evaluable patients with unresectable stage III or IV melanoma in an open-label,

Read the full 158 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE